Sale of 7.7 g of Radium-226 for medical applications
The European Commission, Joint Research Centre (JRC) in Karlsruhe (Germany) plans to sell approximately 7.7 grams of Radium-226 (Ra-226), a valuable resource from its our strategic inventory utilised for cutting-edge research and…
What the buyer needs
- The European Commission, Joint Research Centre (JRC) in Karlsruhe (Germany) plans to sell approximately 7.7 grams of Radium-226 (Ra-226), a valuable resource from its our strategic inventory utilised for cutting-edge…
- This includes applications in the production of Actinium-225 (Ac-225) for the use of targeted alpha therapy.
- Following a surge of demand for Ac-225, Ra-226 material serves as a crucial source material for producing it as well as other valuable medical radioisotopes, such as Lead-212 (Pb-212).
- With a growing demand and limited supply for Ra-226, the JRC Karlsruhe wants to contribute to the medical isotope supply chain.
Procurement signals
- Procedure: EC-JRC/KRU/2025/RP/0012-PIN
- Procedure type: Source procedure code 47396222
- Contract type: Supply contract (31095499)
- Submission method: Electronic submission
- Published: 20 Dec 2024
Procurement categories
CPV labels are not yet mapped locally, so the official category codes are shown as source-backed identifiers.
Programme and geography
Derived from official EU Funding & Tenders portal source fields. Use this as a shortlisting aid; the official tender record remains authoritative.
Source-backed details
Original identifiers and classification fields from the EU tender source.
- EC-JRC/KRU/2025/RP/0012-PIN
- a2c8b963-668e-4f26-8454-11db7332e942-PIN
- Source procedure code 47396222
- Supply contract (31095499)
- 47352548
- Europe/Berlin
- 17 Jun 2026, 21:04 UTC
Full official description
The European Commission, Joint Research Centre (JRC) in Karlsruhe (Germany) plans to sell approximately 7.7 grams of Radium-226 (Ra-226), a valuable resource from its our strategic inventory utilised for cutting-edge research and development in nuclear medical applications. This includes applications in the production of Actinium-225 (Ac-225) for the use of targeted alpha therapy. Following a surge of demand for Ac-225, Ra-226 material serves as a crucial source material for producing it as well as other valuable medical radioisotopes, such as Lead-212 (Pb-212). With a growing demand and limited supply for Ra-226, the JRC Karlsruhe wants to contribute to the medical isotope supply chain. The expertise along with the state-of-the-art assets at JRC Karlsruhe, equips it to contribute effectively to this critical field. This sale is meant to bolster the availability of Ra-226 for medical applications and further the advancement of nuclear medicine.